|
Bextra®
On April 7, 2005, the FDA formally asked Pfizer Pharmaceuticals to voluntarily suspend sales of Bextra® in the U.S. The FDA stated that the risks posed by Bextra® outweighed its benefits. These risks include a high rate of heart attacks, strokes and sometimes a life-threatening skin reaction, Stevens Johnson Syndrome*(for which there is no specific treatment)—as well as other potentially fatal skin hypersensitivity disorders.
Bextra® belongs to a family of pain relievers called NSAIDs. NSAIDs, or Non-Steroidal Anti-Inflammatory Drugs are designed to reduce swelling and inflammation, and are commonly taken to treat several types of arthritis and other types of pain. Bextra® and other NSAIDs such as Vioxx® (this should be a link directly to the Vioxx page) were prescribed as an alternative to other pain medications because they were thought to have fewer gastrointestinal side effects. Unfortunately, these same drugs have been shown to increase cardiovascular risk as well as other severe, life-threatening reactions.
*Symptoms of Stevens Johnson Syndrome include blistering of the mucous membranes that appear as multiple skin lesions, itching, fever, general ill feeling, joint aches, vision abnormalities and eye discharge.
While taking Bextra®, have you or someone you know…
- Suffered a heart attack?
- Suffered a stroke?
- Suffered any type of vascular disease?
- Suffered symptoms of Stevens Johnson Syndrome or other skin reactions?
Did someone you know die from these symptoms after taking Bextra®?
If you answered "yes" to any of these questions, you may be entitled to a recovery for injuries. If you or someone you know has been adversely affected by Bextra®, contact us immediately for a FREE, no obligation consultation by our firm's legal and medical team.
To find out if you have a case, complete our online form or contact our legal team for more information.
—We’re here to help.
Bextra® Links
|
